Jupiter examines ovarian cancer treatment clinical trials

JUPITER - Jupiter is Medical Center registration check suffering in a clinical trial, an investigational therapy for women with Platinum-sensitive ovarian cancer, which has more.

The process is sponsored by Morphotek and deals with an investigational monoclonal antibodies - Farletuzumab-, which can block the protein involved in the development of Platinum-sensitive ovarian cancer tumor cells.

Researchers are going to find out whether a new drug can prolong the duration of the second bus in gals who have relapsed after six months of their last treatment.

You get far more facts (561) 745-5768.

This entry was posted on Wednesday, March 16, 2011 at 12:38 am and is filed under treatment. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.